OR WAIT null SECS
August 05, 2024
Germany’s Medical Research Act allows pharmaceutical companies to keep drug prices confidential.
June 05, 2024
EMA is promoting the use of RWD in decision-making and has started a public consultation to review its draft recommendations.
May 04, 2024
The IDAP pilot scheme is designed to accelerate access to innovative medical devices and is a pioneering legislative proposal in the UK medical device space.
April 02, 2024
The European pharma industry needs to be prepared for the new clinical data requirements.
March 02, 2024
Swissmedic issues updated guidance relating to APIs, temporary authorization, and fast-track authorizations.
February 02, 2024
The UK’s IRP increases flexibility and will help speed up product approvals and patient access to medicines.
January 02, 2024
The EHDS aims to increase access to health data, but how will it impact pharma?
December 02, 2023
What does the 2024 VPAS mean for pharma?
November 02, 2023
The EU’s AI Act is set to become the world’s first comprehensive legal framework for artificial intelligence.
September 28, 2023
The new framework will position the UK as an attractive prospect for new medicine manufacturers.